SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (13501)9/3/1998 7:11:00 AM
From: Jenna  Read Replies (2) of 120523
 
GNE on Aug. 28 watch list.http://www.exchange2000.com/~wsapi/investor/reply-5610957 did finally get that FDA approval, stock started moving yesterday.FDA Advisory Panel Recommends Two Breast-Cancer Drugs

By Robert Langreth, Staff Reporter of The Wall Street Journal
BETHESDA, Md. -- Government advisers cleared the way for the approval of the firstdrug shown to reduce the risk of breast cancer in healthy women, though they cautioned the drug's benefits haven't been proved beyond a few years.
In a landmark decision, a Food and Drug Administration scientific advisory panel overwhelmingly voted to recommend approval of Zeneca Group PLC's Nolvadex, generically called tamoxifen, for reducing the incidence of breast cancer in healthy women with anelevated risk of developing the disease. But, in a nuanced ruling, the committee stopped short of agreeing that the drug could actually prevent breast cancer over the long term,ruling that this hasn't yet been proved by clinical studies.
Separately, in a second major decision, the FDA panel recommended the approval of a drug to treat breast cancer, Genentech Inc.'s Herceptin, believed to be one of the fewsignificant advances for treating advanced cases of the disease. Researchers are excited
about the drug because it is the first of an expected wave of new therapies that directly attack cancer's genetic and biological causes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News